This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2015-2020.
Company Filing History:
Years Active: 2015-2020
Title: Miki Matsuba: Innovator in Antibacterial Compounds
Introduction
Miki Matsuba is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of antibacterial compounds, particularly in the fight against multidrug-resistant tuberculosis. With a total of 2 patents, her work is crucial in developing effective treatments for serious bacterial infections.
Latest Patents
Miki Matsuba's latest patents include a piperidine derivative aimed at providing a compound with excellent antibacterial activity against multidrug-resistant tuberculosis bacteria and non-tuberculous acid-fast bacteria. This compound can be utilized to diagnose, prevent, and treat tuberculosis. Another notable patent is for a novel 6,7-dihydroimidazo[2,1-b][1,3]oxazine compound, which exhibits excellent bactericidal action against tubercle bacilli, multidrug-resistant tubercle bacilli, and atypical acid-fast bacilli.
Career Highlights
Miki Matsuba is currently associated with Otsuka Pharmaceutical Company, Limited, where she continues her research and development efforts. Her innovative work has positioned her as a key figure in the pharmaceutical industry, particularly in the area of infectious diseases.
Collaborations
Miki collaborates with notable colleagues such as Makoto Matsumoto and Yoshikazu Kawano, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Miki Matsuba's contributions to antibacterial research are invaluable, particularly in addressing the challenges posed by drug-resistant bacteria. Her patents reflect her commitment to improving public health through innovative solutions.